Progenika Biopharma, S.A.
Records under this name other than the patents Progenika Biopharma, S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Showing 1 to 6 of 6 · Back to Progenika Biopharma, S.A.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,215,376 | Mitochondrial nucleic acid depletion and detection Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,124,331 | In Vitro Method to Detect Bladder Transitional Cell Carcinoma Formerly held Term ended Term ended Sep 14, 2026 · High confidence | Term ended | Term ended Sep 14, 2026 | High confidence |
| US 8,712,696 | Methods of prognosing a rheumatoid arthritis remission phenotype Lapsed on the fee record Ended Apr 29, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 29, 2026 | USPTO record |
| US 8,669,049 | Method and device for the detection of mutations in isolated gene sequences of the low-density lipoprotein receptor (LDL-r) which is associated with familial hypercholesterolemia Lapsed on the fee record Ended Mar 11, 2026 · USPTO record | Lapsed on the fee record | Ended Mar 11, 2026 | USPTO record |
| US 8,835,111 | Genotyping tool for improving the prognostic and clinical management of MS patients Lapsed on the fee record Ended Sep 16, 2018 · USPTO record | Lapsed on the fee record | Ended Sep 16, 2018 | USPTO record |
| US 8,296,073 | Diagnostic method Formerly held Lapsed on the fee record Ended Oct 23, 2016 · USPTO record | Lapsed on the fee record | Ended Oct 23, 2016 | USPTO record |